Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism

Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts

(2017) Mizuho Kittaka et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone

(2017) Suma Uday et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Denosumab: an Emerging Therapy in Pediatric Bone Disorders

(2017) Alison M. Boyce   Current Osteoporosis Reports

Severe hypercalcemia following denosumab treatment in a juvenile patient

(2015) Nokitaka Setsu et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Osteosclerosis induced by denosumab

(2015) Eisuke Kobayashi et al.   LANCET

Management of Central Giant Cell Granuloma With Subcutaneous Denosumab Therapy

(2014) Aparna Naidu et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Denosumab and bisphosphonates: Different mechanisms of action and effects

(2010) Roland Baron et al.   BONE